Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIRA:LN
117.00
USd
0.80
0.68%
As of 4/23/2018
Fund Type
Unit Trust
52Wk Range
99.64 - 129.00
1 Yr Return
15.16%
YTD Return
3.36%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
117.80
52Wk Range
99.64 - 129.00
1 Yr Return
14.82%
YTD Return
3.36%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/23/2018)
117
Total Assets (m GBP) (on 04/23/2018)
466.381
Inception Date
01/23/2015
Last Dividend (on 03/01/2018)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
0.00%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
-
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100